Anne Gussow

Array ( [id] => 5391207 [patent_doc_number] => 20090208520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'PRRSV GP5 BASED COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/111871 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 14367 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208520.pdf [firstpage_image] =>[orig_patent_app_number] => 12111871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449871 [patent_doc_number] => 20100145023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Optimized Nucleotide Sequences of VB6-845 For Expression of Recombinant Proteins' [patent_app_type] => utility [patent_app_number] => 12/596188 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5116 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145023.pdf [firstpage_image] =>[orig_patent_app_number] => 12596188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543619 [patent_doc_number] => 08318911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Anti-EpCAM antibody and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/594559 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8549 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820421 [patent_doc_number] => 20080226629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/056724 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30265 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226629.pdf [firstpage_image] =>[orig_patent_app_number] => 12056724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5454853 [patent_doc_number] => 20090070890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Product' [patent_app_type] => utility [patent_app_number] => 12/055743 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24121 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20090070890.pdf [firstpage_image] =>[orig_patent_app_number] => 12055743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718615 [patent_doc_number] => 20080241137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/055014 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14529 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241137.pdf [firstpage_image] =>[orig_patent_app_number] => 12055014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5270883 [patent_doc_number] => 20090074659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 12/052495 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6159 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074659.pdf [firstpage_image] =>[orig_patent_app_number] => 12052495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330225 [patent_doc_number] => 20090110702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Mesothelin Vaccines and Model Systems and Control of Tumors' [patent_app_type] => utility [patent_app_number] => 12/049763 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30069 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110702.pdf [firstpage_image] =>[orig_patent_app_number] => 12049763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954535 [patent_doc_number] => 20080187559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Method of Treating Cancer Cells to Create a Modified Cancer Cell That Provokes an Immunogenic Response' [patent_app_type] => utility [patent_app_number] => 12/044107 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14855 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187559.pdf [firstpage_image] =>[orig_patent_app_number] => 12044107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6297072 [patent_doc_number] => 20100160757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'DEVICE AND METHOD FOR ASSESSING BLOOD GLUCOSE CONTROL' [patent_app_type] => utility [patent_app_number] => 12/040458 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8631 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160757.pdf [firstpage_image] =>[orig_patent_app_number] => 12040458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472213 [patent_doc_number] => 20100041074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING ANTI-GRP78 ANTIBODY AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/449778 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30187 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041074.pdf [firstpage_image] =>[orig_patent_app_number] => 12449778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245731 [patent_doc_number] => 20100136030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'ANTAGONIST OX40 ANTIBODIES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/526550 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35317 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136030.pdf [firstpage_image] =>[orig_patent_app_number] => 12526550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697787 [patent_doc_number] => 20080219971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'HUMAN ANTI-CD100 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/030356 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45812 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219971.pdf [firstpage_image] =>[orig_patent_app_number] => 12030356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44466 [patent_doc_number] => 07777019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells' [patent_app_type] => utility [patent_app_number] => 12/030828 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19522 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777019.pdf [firstpage_image] =>[orig_patent_app_number] => 12030828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580947 [patent_doc_number] => 07834154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Anti-ROBO4 antibodies and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/028124 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 56 [patent_no_of_words] => 57687 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834154.pdf [firstpage_image] =>[orig_patent_app_number] => 12028124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440961 [patent_doc_number] => 20090092600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO THE REGULATION OF MUC1 BY HSF1 AND STAT3' [patent_app_type] => utility [patent_app_number] => 12/024692 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 48235 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092600.pdf [firstpage_image] =>[orig_patent_app_number] => 12024692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348825 [patent_doc_number] => 20090004186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'EFFECTOR FUNCTION ENHANCED RECOMBINANT ANTIBODY COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/019160 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 51303 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004186.pdf [firstpage_image] =>[orig_patent_app_number] => 12019160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452073 [patent_doc_number] => 20090068110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/959783 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 83451 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068110.pdf [firstpage_image] =>[orig_patent_app_number] => 11959783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801230 [patent_doc_number] => 08129502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/938846 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14048 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129502.pdf [firstpage_image] =>[orig_patent_app_number] => 11938846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379377 [patent_doc_number] => 20090191216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Antibody or a fragment thereof, having neutralizing activity against HIV' [patent_app_type] => utility [patent_app_number] => 11/979326 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9742 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191216.pdf [firstpage_image] =>[orig_patent_app_number] => 11979326 [rel_patent_id] =>[rel_patent_doc_number] =>)